Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997026894 - INTRAVENOUS MAGNESIUM GLUCONATE FOR TREATMENT OF CONDITIONS CAUSED BY EXCESSIVE OXIDATIVE STRESS DUE TO FREE RADICAL DISTRIBUTION

Publication Number WO/1997/026894
Publication Date 31.07.1997
International Application No. PCT/US1997/001237
International Filing Date 24.01.1997
Chapter 2 Demand Filed 11.08.1997
IPC
A61K 31/191 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
191Acyclic acids having two or more hydroxy groups, e.g. gluconic acid
A61K 33/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
06Aluminium, calcium or magnesium; Compounds thereof
CPC
A61K 31/191
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
191having two or more hydroxy groups, e.g. gluconic acid
A61K 33/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
06Aluminium, calcium or magnesium; Compounds thereof ; , e.g. clay
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
Applicants
  • WEGLICKI, William, B. [US]/[US]
Inventors
  • WEGLICKI, William, B.
Agents
  • DREHKOFF, W., Dennis
Priority Data
60/011,05725.01.1996US
null24.01.1997US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) INTRAVENOUS MAGNESIUM GLUCONATE FOR TREATMENT OF CONDITIONS CAUSED BY EXCESSIVE OXIDATIVE STRESS DUE TO FREE RADICAL DISTRIBUTION
(FR) GLUCONATE DE MAGNESIUM INTRAVEINEUX POUR LE TRAITEMENT D'ETATS CAUSES PAR UN STRESS OXYDANT IMPUTABLE A LA REPARTITION DES RADICAUX LIBRES
Abstract
(EN)
The intravenous use of magnesium gluconate to substantially block free radical surge in the treatment of ischemia/reperfusion (I/R) injury due to oxidative stress.
(FR)
La présente invention concerne l'utilisation du gluconate de magnésium pour bloquer sensiblement la montée du taux de radicaux libres en cas de traitement de lésions d'ischémie ou de reperfusion par suite de stress oxydant.
Latest bibliographic data on file with the International Bureau